147 related articles for article (PubMed ID: 37094546)
21. Clinical significance of 'double-hit' and 'double-expression' lymphomas.
Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X
J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842
[TBL] [Abstract][Full Text] [Related]
22. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome.
Michaux L; Wlodarska I; Theate I; Stul M; Scheiff JM; Deneys V; Ferrant A; Hagemeijer A
Ann Hematol; 2004 Sep; 83(9):578-83. PubMed ID: 15138714
[TBL] [Abstract][Full Text] [Related]
23. [Clinicopathologic and cytogenetic features of 114 Chinese mantle cell lymphoma cases].
Li M; Wang XY; Xue XM; Liu CL; Huang X; Sun L; Gao ZF
Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):738-42. PubMed ID: 23336228
[TBL] [Abstract][Full Text] [Related]
24. CCND1-IGH Fusion-Amplification and MYC Copy Number Gain in a Case of Pleomorphic Variant Mantle Cell Lymphoma.
Miao Y; Lin P; Wang W; Jeffrey Medeiros L; Lu X
Am J Clin Pathol; 2016 Dec; 146(6):747-752. PubMed ID: 28028120
[TBL] [Abstract][Full Text] [Related]
25. Unusual concomitant rearrangements of Cyclin D1 and MYC genes in blastoid variant of mantle cell lymphoma: Case report and review of literature.
Delas A; Sophie D; Brousset P; Laurent C
Pathol Res Pract; 2013 Feb; 209(2):115-9. PubMed ID: 23313364
[TBL] [Abstract][Full Text] [Related]
26. Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region.
Maravelaki S; Burford A; Wotherspoon A; Joshi R; Matutes E; Catovsky D; Brito-Babapulle V
Cancer Genet Cytogenet; 2004 Oct; 154(1):67-71. PubMed ID: 15381376
[TBL] [Abstract][Full Text] [Related]
27. Involvement of the CCND1 gene in hairy cell leukemia.
de Boer CJ; Kluin-Nelemans JC; Dreef E; Kester MG; Kluin PM; Schuuring E; van Krieken JH
Ann Oncol; 1996 Mar; 7(3):251-6. PubMed ID: 8740788
[TBL] [Abstract][Full Text] [Related]
28. Rapid detection of the t(11;14) translocation in mantle cell lymphoma by interphase fluorescence in situ hybridization on archival cytopathologic material.
Bentz JS; Rowe LR; Anderson SR; Gupta PK; McGrath CM
Cancer; 2004 Apr; 102(2):124-31. PubMed ID: 15098257
[TBL] [Abstract][Full Text] [Related]
29. [Interphase FISH analysis of frozen or fixed tissues for the detection of t(11;14) (q13;q32) in mantle cell lymphoma].
Belaud-Rotureau MA; Dubus P; Parrens M; Turmo M; Lacroute G; Taine L; Marit G; Reiffers J; Vago P; De Mascarel A; Merlio JP
Morphologie; 2001 Sep; 85(270):15-22. PubMed ID: 11723817
[TBL] [Abstract][Full Text] [Related]
30. Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model.
M'kacher R; Farace F; Bennaceur-Griscelli A; Violot D; Clausse B; Dossou J; Valent A; Parmentier C; Ribrag V; Bosq J; Carde P; Turhan AG; Bernheim A
Cancer Genet Cytogenet; 2003 May; 143(1):32-8. PubMed ID: 12742154
[TBL] [Abstract][Full Text] [Related]
31. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.
Hui P; Howe JG; Crouch J; Nimmakayalu M; Qumsiyeh MB; Tallini G; Flynn SD; Smith BR
Leuk Lymphoma; 2003 Aug; 44(8):1385-94. PubMed ID: 12952233
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
[No Abstract] [Full Text] [Related]
33. [Clinicopathologic characteristics and prognositic indicators of tonsillar mantle cell lymphoma].
Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):158-162. PubMed ID: 29534352
[No Abstract] [Full Text] [Related]
34. Double-hit mantle cell lymphoma with MYC gene rearrangement or amplification: a report of four cases and review of the literature.
Setoodeh R; Schwartz S; Papenhausen P; Zhang L; Sagatys EM; Moscinski LC; Shao H
Int J Clin Exp Pathol; 2013; 6(2):155-67. PubMed ID: 23330001
[TBL] [Abstract][Full Text] [Related]
35. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
36. High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry.
Lešková K; Szépe P; Balhárek T; Barthová M; Janáková Ľ; Farkašová A; Plank L
Neoplasma; 2022 Jul; 69(4):957-964. PubMed ID: 35652622
[TBL] [Abstract][Full Text] [Related]
37. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades.
Swerdlow SH; Williams ME
Hum Pathol; 2002 Jan; 33(1):7-20. PubMed ID: 11823969
[TBL] [Abstract][Full Text] [Related]
38. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
39. Characterization of genetic changes in MCL by interphase FISH on tissue sections.
Sander B; Wallblom A; Ekroth A; Porwit A; Kimby E
Leuk Lymphoma; 2007 Jul; 48(7):1344-52. PubMed ID: 17613764
[TBL] [Abstract][Full Text] [Related]
40. High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival.
Yi S; Zou D; Li C; Zhong S; Chen W; Li Z; Xiong W; Liu W; Liu E; Cui R; Ru K; Zhang P; Xu Y; An G; Lv R; Qi J; Wang J; Cheng T; Qiu L
Oncotarget; 2015 Dec; 6(39):42362-71. PubMed ID: 26517511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
